Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 10 results.
User Information
Export Records
  1. 1.   Innate Immune Stimulation Using 3D Wireframe DNA Origami
  2. Du, Rebecca R; Cedrone,Edward; Romanov, Anna; Falkovich, Reuven; Dobrovolskaia,Marina; Bathe, Mark
  3. ACS Nano. 2022, Dec 02;
  1. 2.   Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
  2. Conlon, Kevin; Watson, Dionysios C; Waldmann, Thomas A; Valentin,Antonio; Bergamaschi,Cristina; Felber,Barbara; Peer, Cody J; Figg, William D; Potter, E Lake; Roederer, Mario; McNeel, Douglas G; Thompson, John A; Gupta, Sumati; Leidner, Rom; Wang-Gillam, Andrea; Parikh, Nehal S; Long, Debby; Kurtulus, Sema; Ho Lee, Lang; Chowdhury, Niladri Roy; Bender, Florent; Pavlakis,George
  3. Journal for immunotherapy of cancer. 2021, Nov; 9(11):
  1. 3.   Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury
  2. Peukert, Konrad; Fox, Mario; Schulz, Susanne; Feuerborn, Caroline; Frede, Stilla; Putensen, Christian; Wrigge, Hermann; Kummerer, Beate Mareike; David, Sascha; Seeliger, Benjamin; Welte, Tobias; Latz, Eicke; Klinman,Dennis; Wilhelm, Christoph; Steinhagen, Folkert; Bode, Christian
  3. American Journal of Respiratory and Critical Care Medicine. 2021, Jul 1; 204(1): 53-63.
  1. 4.   Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery
  2. Gregg, Kelsey A.; Harberts, Erin; Gardner, Francesca M.; Pelletier, Mark R.; Cayatte, Corinne; Yu, Li; McCarthy, Michael P.; Marshall, Jason; Ernst, Robert K.
  3. MBIO. 2017, May-Jun; 8(3):
  1. 5.   Interferon: Cellular executioner or white knight?
  2. Maher, S. G.; Romero-Weaver, A. L.; Scarzello, A. J.; Gamero, A. M.
  3. Current Medicinal Chemistry. 2007 14(12): 1279-1289.
  1. 6.   Marine natural products and related compounds in clinical and advanced preclinical trials
  2. Newman, D. J.; Cragg, G. M.
  3. Journal of Natural Products. 2004, AUG; 67(8): 1216-1238.
  1. 7.   The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation
  2. Asefa, B.; Klarmann, K. D.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Keller, J. R.
  3. Blood Cells Molecules and Diseases. 2004, JAN-FEB; 32(1): 155-167.
  1. 8.   Update on D-Ala-Peptide T-Amide (DAPTA): A viral entry inhibitor that blocks CCR5 chemokine receptors
  2. Ruff, M. R.; Polianova, M.; Yang, Q. E.; Leoung, G. S.; Ruscetti, F. W.; Pert, C. B.
  3. Current HIV Research. 2003 1(1): 51-67.
  1. 9.   Conditioned immune response to interferon-gamma in humans
  2. Longo, D. L.; Duffey, P. L.; Kopp, W. C.; Heyes, M. P.; Alvord, W. G.; Sharfman, W. H.; Schmidt, P. J.; Rubinow, D. R.; Rosenstein, D. L.
  3. Clinical Immunology. 1999 90(2): 173-181.
  1. 10.   Detection of Beta-Glucan Contamination in Nanoparticle Formulations
  2. Neun,Barry; Dobrovolskaia,Marina
  3. Methods in molecular biology (Clifton, N.J.). 2024 2789: 101-108.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel